enolate intermediate in which rotation around the C4–C49 exocyclic
Notes and references
bond is possible (structures I9 and V9, Scheme 2).
1 See for example: (a) G. Lagler, Adv. Carbohydr. Chem. Biochem., 1990,
48, 319–384; (b) B. Winchester and G. W. J. Fleet, Glycobiology, 1992, 2,
199–210; (c) M. J. Schneider, in Alkaloids: Chemical and Biological
Perspectives, ed. S. W. Pelletier, Pergamon: Oxford, 1996; vol. 10,
pp. 155–299; (d) D. O’Hagan, Nat. Prod. Rep., 1997, 14, 637–651; (e)
N. Asano, R. J. Nash, R. J. Molyneux and G. W. J. Fleet, Tetrahedron:
Asymmetry, 2000, 11, 1645–1680; (f) A. A. Watson, G. W. J. Fleet,
N. Asano, R. J. Molyneux and R. J. Nash, Phytochemistry, 2001, 56,
265–295.
2 Recent reviews: (a) P. D. Bailey, P. A. Millwood and P. D. Smith,
Chem. Commun., 1998, 633–640; (b) A. Mitchinson and A. Nadin,
J. Chem. Soc., Perkin Trans. 1, 2000, 2862–2892; (c) S. Laschat and
T. Dickner, Synthesis, 2000, 1781–1813; (d) P. M. Weintraub, J. S. Sabol,
J. M. Kane and D. R. Borcherding, Tetrahedron, 2003, 59, 2953–2989;
(e) M. G. P. Buffat, Tetrahedron, 2004, 60, 1701–1729.
With this background information in hand,
a possible
mechanism for the formation of compounds with the opposite
configuration at C2 is outlined in Scheme 2. The initially formed
dienolate I/I9 is re-protonated at the piperidine nitrogen to afford
zwitterion II, in which epimerization at C2 is possible through a
retro 1,6/1,6 addition sequence in which there is a 1,5 functionality
distance between the carbonyl group and the amino group.
Deprotonation of zwitterion IV and subsequent protonation of
dienolate V/V9 would lead to the formation of compounds 4E
and 4Z. This process is mediated by a base strong enough to
accept a proton from C3 with a conjugate acid that is acidic
enough to transfer a proton to the piperidine nitrogen. Of the
bases tested this requirement is only fulfilled by the amidine type
bases DBU and DBN. Initial deprotonation at C5 is also possible
and the enolate generated would evolve to yield the starting
3 For a review on this subject see: H. P. Husson and J. Royer, Chem. Soc.
Rev., 1999, 28, 383–394.
4 Leading references: (a) D. L. Comins, S. P. Joseph and R. R. Goehring,
J. Am. Chem. Soc., 1994, 116, 4719–4728; (b) J. Kuethe and
D. L. Comins, Org. Lett., 1999, 1, 1031–1033 and references therein.
5 For leading references see: N. Toyoka, K. Tanaka, T. Momose,
J. W. Daly and H. M. Garraffo, Tetrahedron, 1997, 53, 9553–9574 and
references therein.
6 (a) A. G. Brewster, S. Broady, C. E. Davies (ne´e Mills), T. D. Heightman,
S. A. Hermitage, M. Hughes, M. G. Moloney and G. Woods, Org.
Biomol. Chem., 2004, 2, 1031–1043; (b) A. G. Brewster, S. Broady,
M. Hughes, M. G. Moloney and G. Woods, Org. Biomol. Chem., 2004,
2, 1800–1841.
7 (a) R. Badorrey, C. Cativiela, M. D. D´ıaz-de-Villegas and J. A. Ga´lvez,
Tetrahedron Lett., 1997, 38, 2547–2550; (b) R. Badorrey, C. Cativiela,
M. D. D´ıaz-de-Villegas and J. A. Ga´lvez, Tetrahedron, 1999, 55,
7601–7612.
8 R. Badorrey, C. Cativiela, M. D. D´ıaz-de-Villegas and J. A. Ga´lvez,
Tetrahedron, 1999, 58, 341–354.
9 (a) J. W. Skiles, P. P. Giannoussis and K. R. Fales, Bioorg. Med. Chem.
Lett., 1996, 6, 963–966; (b) P. S. Watson, B. Jiang and B. Scott, Org.
Lett., 2000, 2, 3679–3681.
10 (a) B. E. Maryanoff and A. B. Reitz, Chem. Rev., 1989, 89, 863–927; (b)
S. E. Kelly, in Comprehensive Organic Synthesis, ed. B. M. Trost and
I. Fleming, Pergamon Press: Oxford, 1991, vol. 1, chap. 3.1.9; (c) Ylides
and Imines of Phosphorus, ed. A. W. Johnson, John Wiley & Sons, Inc.:
New York, 1993; (d) Phosphorus Ylides: Chemistry and Applications in
Organic Synthesis; Wiley-VCH: New York, 1999.
11 G. Wittig and G. Geissler, Liebigs Ann. Chem., 1953, 580, 44–57.
12 W. S. Wadsworth and W. D. Emmons, J. Am. Chem. Soc., 1961, 83,
1733–1738.
13 M. A. Blanchette, W. Choy, J. T. Davis, A. P. Essenfeld, S. Masamune,
W. R. Roush and T. Sakai, Tetrahedron Lett., 1984, 25, 2183–2186.
14 E/Z configurations for compounds 3E, 4E and 4Z were clearly
determined by a series of selective 1D gradient enhanced nuclear
Overhauser enhancement spectroscopy (ge-1D NOESY) experiments
and the Z configuration of compound 3Z was established by
elimination.
compounds.
A retro-conjugate addition/conjugate addition
sequence has been reported previously in 2,5-disubstituted
pyrrolidine alkylations.15
Isolation or trapping of intermediates was not possible but the
reaction was followed by 1H NMR spectroscopy and the
appearance of signals at ca. 6.0 and 6.5 ppm was observed.
These signals can be attributed to protons bonded to the highly
conjugated disubstituted double bond of compound III.
On the basis of these results we reasoned that to avoid
epimerization at C2 the HWE reaction must be conducted using
LDA as the base. Indeed, reaction of compound 2 with triethyl
phosphonoacetate (3.0 eq.) in the presence of LDA (3.5 eq.) led to
the exclusive formation of compounds 3E and 3Z in a 97/3 ratio in
nearly quantitative yield (97%) after 14 h. This approach
constitutes a valuable synthetic methodology for the synthesis of
compounds with the R configuration at C2.
In conclusion, a mechanism that accounts for the unexpected
epimerization at C2 in the Horner–Wadsworth–Emmons reaction
of 2-substituted-4-oxopiperidines has been proposed and is
supported by experimental results. This study has established the
optimal conditions for the diastereodivergent synthesis of E/Z
mixtures of 2-[(S)-1,2-dibenzyloxyethyl]-4-ethoxycarbonylmethy-
lene-N-[(S)-1-phenylethyl]piperidine of R and S configuration at
C2 starting from 4-oxopiperidine 2.
The authors wish to thank the Spanish MCYT and FEDER
(Project CTQ2004-05358) and the Diputacio´n General de Arago´n
for financial support and the Spanish MCYT for a predoctoral
fellowship (P. E.).
15 (a) S. R. Hussaini, M. G. Moloney and G. Woods, Org. Biomol. Chem.,
2003, 1, 1838–1841; (b) S. R. Hussaini, M. G. Moloney and G. Woods,
Tetrahedron Lett., 2004, 45, 1125–1127.
3422 | Chem. Commun., 2006, 3420–3422
This journal is ß The Royal Society of Chemistry 2006